logo

iStock Rating

B
Details...
Enter Symbol click to research

Dynavax Technologies Corporation (NASDAQ: DVAX)

Sector: Medical

Current Price : $2.54

52 Week Low
$1.8352 Week High
$5.26
 

DYNAVAX TE(NSDQ:DVAX)
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax''s clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
# Employees: 167
Address: 2929 SEVENTH STREET SUITE 100,BERKELEY,CA,USA
Phone: 5108485100
Fax: 510-848-1327
Website: www.dynavax.com
Email: IR@dynavax.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Arnold L. Oronsky (Chairman)
Dino Dina (Chief Executive Officer)
Jennifer Lew (Vice President; and Finance)
Dennis A. Carson (Director)
Francis R. Cano (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 4/26/2013
Mean EPS (Next Qtr): ($0.10)
Mean EPS (Year): ($0.40)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 4
Shares Performance
Period dvax Compare to S&P
YTD -16.14 % -23.10 %
4 Weeks 8.64 % 8.75 %
12 Weeks -21.38 % -24.02 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1977575
Shares Outstanding: 182M
Market Cap: $0.44B
52 Week High: $5.26
52 Week Low: $1.83
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 dvax split by factor of 0.090
Earnings Performance
EPS Growth in Last Quarter: -10.00 %
EPS Growth in Last Year: -266.67 %
Sales Growth in Last Quarter: -37.16 %
Sales Growth in Last Quarter: -84.20 %
Financials
Qtr Book Value: $3.72
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.